Empagliflozin (BI 10773), a Potent and Selective SGLT2...

Clinical Pharmacology in Drug Development 2013 / 04 Vol. 2; Iss. 2

Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects

Seman, Leo, Macha, Sreeraj, Nehmiz, Gerhard, Simons, Gudrun, Ren, Bailuo, Pinnetti, Sabine, Woerle, Hans J., Dugi, Klaus
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Language:
english
Journal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.16
Date:
April, 2013
File:
PDF, 451 KB
english, 2013
Conversion to is in progress
Conversion to is failed